Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERN1 | O75460 | 5/20 | 0.46 |
| ▸ | CA1 | P00915 | 3/20 | 0.43 |
| ▸ | CA2 | P00918 | 3/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | CA12 | O43570 | 2/20 | 0.43 |
| ▸ | CA7 | P43166 | 2/20 | 0.43 |
| ▸ | CA9 | Q16790 | 2/20 | 0.43 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.43 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.43 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.43 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.42 |
| ▸ | PTPN6 | P29350 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | TNF | P01375 | 1/20 | 0.41 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14877998 | 0.91 | ERN1 (0.46) | ERN1CA1CA2ALDH1A1CA12 | |
| SCHEMBL166800 | 0.82 | APP (0.49) | ERN1CA1CA2ALDH1A1CA12 | |
| SCHEMBL1527102 | 0.81 | HTT (0.49) | ERN1ALDH1A1CA9KDM4ECYP3A4 | |
| SCHEMBL10111663 | 0.79 | ERN1 (0.39) | ERN1CA1CA2ALDH1A1CA12 | |
| SCHEMBL268435 | 0.79 | ERN1 (0.39) | ERN1CA1CA2ALDH1A1CA12 | |
| SCHEMBL17660183 | 0.78 | ERN1 (0.52) | ERN1 | |
| SCHEMBL460201 | 0.78 | CA1 (0.56) | CA1CA2ALDH1A1CA12CA7 | |
| SCHEMBL16077669 | 0.78 | ERN1 (0.46) | ERN1CA1CA2ALDH1A1CA12 | |
| SCHEMBL28709846 | 0.77 | KMT2A (0.54) | ERN1ALDH1A1KDM4ECYP3A4MAPT | |
| Boric Acid SCHEMBL28474920 | 0.77 | CA1 (0.50) | CA1CA2ALDH1A1CA12CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11041812-B2 | Fluorogenic pH-sensitive dyes, film and kit comprising the same | SFC CO., LTD. (KR) | 2021-06-22 | — | — | US | disclosed |
| US-10473666-B2 | Dye compounds | SFC CO., LTD. (KR) | 2019-11-12 | — | — | US | disclosed |
| US-20180203015-A1 | DYE COMPOUNDS | SFC CO., LTD. (KR) | 2018-07-19 | — | — | US | disclosed |
| US-20180203015-A1 | DYE COMPOUNDS | SFC CO., LTD. (KR) | 2018-07-19 | — | — | US | disclosed |
| WO-2017010852-A1 | DYE COMPOUND | 에스에프씨 주식회사 | 2017-01-19 | — | — | WO | disclosed |
| EP-2236508-B1 | Reactive Heterocycle-Substituted 7-Hydroxycoumarins and Their Conjugates | BECTON DICKINSON CO (US) | 2015-08-26 | — | — | EP | disclosed |
| CN-101914093-B | The umbelliferone class of reactive heterocyclic substituted and their binding substances | BECTON DICKINSON AND CO. (US) | 2015-08-26 | — | — | CN | disclosed |
| US-8431416-B2 | Reactive heterocycle-substituted 7-hydroxycoumarins and their conjugates | BECTON, DICKINSON AND COMPANY (US) | 2013-04-30 | — | — | US | disclosed |
| US-8318953-B2 | Reactive coumarin derivatives and their use in cellular analyses | AAT BIOQUEST, INC. (US) | 2012-11-27 | — | — | US | disclosed |
| US-20110318772-A1 | REACTIVE COUMARIN DERIVATIVES AND THEIR USE IN CELLULAR ANALYSES | AAT BIOQUEST, INC. (US) | 2011-12-29 | — | — | US | disclosed |
| US-20100255504-A1 | Reactive Heterocycle-Substituted 7-Hydroxycoumarins and Their Conjugates | BECTON, DICKINSON AND COMPANY (US) | 2010-10-07 | — | — | US | disclosed |
| EP-2236508-A1 | Reactive Heterocycle-Substituted 7-Hydroxycoumarins and Their Conjugates | Becton, Dickinson and Company (US) | 2010-10-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110318772-A1 | REACTIVE COUMARIN DERIVATIVES AND THEIR USE IN CELLULAR ANALYSES | CYP3A7, XPO7, HCCS | ERN1 2008/4885CA1 3288/4885CA2 1887/4885 |
| US-20100255504-A1 | Reactive Heterocycle-Substituted 7-Hydroxycoumarins and Their Conjugates | HLCS, CD44, HCCS | ERN1 4519/4885CA1 2577/4885CA2 2999/4885 |
| US-10473666-B2 | Dye compounds | SQOR, MT-ND5, MT-ND2 | ERN1 4024/4885CA1 1270/4885CA2 231/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.